Abstract
(Table Presented) Vaccines offer protection against infectious diseases, but the successes from the years of development have been mixed. Some diseases have been effectively controlled or eradicated through vaccination, whereas treatments for a number of diseases, especially the reemerging diseases, currently do not exist. Improved understanding of pathogen variability as well as of the diversity of the human immune system, plus technological advances in genetic and molecular biology provide better insights in the host-pathogen interaction and new avenues for vaccine development. In this article we discuss the latest trends in vaccine research with focus on epitope-based DNA vaccines and trafficking components for efficient vaccine delivery. These approaches are promising in dealing with host and pathogen diversity as well as with diversity within human populations.
| Original language | English |
|---|---|
| Pages (from-to) | 383-392 |
| Number of pages | 10 |
| Journal | Drug Development Research |
| Volume | 62 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2004 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Free Keywords
- Bioinformatics
- Hot spots
- T-cell epitopes
- Vaccines
ASJC Scopus subject areas
- Drug Discovery
Fingerprint
Dive into the research topics of 'New technologies for vaccine development'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver